SCOTT STEIN: Open Payments
NPI 1659453306 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 108 payments from 17 companies in 2025. Trend: 2023 $2,426 · 2024 $2,145 · 2025 $2,243
Food & beverage: $2,057Education: $186
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 25 | $519 |
| Mallinckrodt Hospital Products Inc. | 11 | $320 |
| ABBVIE INC. | 20 | $279 |
| AstraZeneca Pharmaceuticals LP | 11 | $243 |
| Janssen Biotech, Inc. | 8 | $161 |
| E.R. Squibb & Sons, L.L.C. | 6 | $121 |
| UCB, Inc. | 5 | $110 |
| Gilead Sciences, Inc. | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| Lilly USA, LLC | 2 | $53 |
Products named: ACTHAR, SAPHNELO, Otezla, TREMFYA, RINVOQ, SKYRIZI, ORENCIA, Bimzelx.
Industry payments across TX — which companies pay providers there.
